Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca Pharma India Ltd. Board/Management Information 2023

Sep 15, 2023

60656_rns_2023-09-15_915e4eb9-093e-4cbf-a96b-854ce9c4afe8.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [452 x 78] intentionally omitted <==

September 15, 2023

The Manager- Listing BSE Limited

Corporate Relationship Dept., 5[th] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai – 400 001

The Manager- Listing National Stock Exchange of India Limited Exchange Plaza, 5[th] Floor, Plot No. C/1, G - Block Bandra –Kurla Complex, Bandra (E), Mumbai – 400 051

Dear Sir(s),

Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure - Requirements) Regulations, 2015 Appointment of Senior Management Personnel

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company has approved the appointment of Mr. Praveen Akkinepally as the Business Unit Head – Oncology with effect from November 1, 2023. Mr. Praveen will be part of the Senior Management team of the Company.

In this regard, please find the details as required under the SEBI Circular SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated July 13, 2023 attached herewith as Annexure – A .

Kindly take the above information on record.

For AstraZeneca Pharma India Limited

MANAS Digitally signed by MANASA RAMA A RAMA Date: 2023.09.15 10:12:52 +05'30'

Manasa. R Company Secretary

==> picture [453 x 64] intentionally omitted <==

==> picture [452 x 78] intentionally omitted <==

Annexure - A

Appointment of Mr. Praveen Akkinepally as Business Unit Head - Oncology

Sl. No Particulars Details
1 Reason
for
change
viz.
appointment,
resignation,
removal, death or otherwise;
Appointment of Mr. Praveen Akkinepally as
Business Unit Head - Oncology.
2 Date of appointment and term
of appointment
Effective November 1, 2023
Term of appointment – Full – time employement
3 Brief Profile Mr. Praveen Akkinepally holds an MBA from The
University of Michigan, Ross School of Business
and an Master in Public Health from Johns Hopkins
University, Bloomberg School of Public Health.
He has been recognized by Diversity MBA
Magazine in their annual Top 100 Under 50 list of
Executive and Emerging Leaders.
Currently, Mr. Praveen Akkinepally is the Head of
Lung Cancer Commercialization, AstraZeneca
Gaithersburg, MD, USA.
4 Disclosure of relationships
between directors
Not Applicable

==> picture [453 x 64] intentionally omitted <==